Health
Clinical efficacy and safety of neratinib for breast cancer | DDDT – Dove Medical Press
Clinical efficacy & safety of neratinib for the treatment of adult patients with advanced or metastatic HER2 positive breast…
Introduction
Breast cancer is the most common malignancy in women (approximately 30% of total), where it represents the first cause of cancer-related death.1
From a biological point of view, breast cancer can be classified into molecularly defined subtypes,…
Continue Reading
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Business19 hours agoSolid superannuation gains continue to roll in
-
General9 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate